Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preemptive etoricoxib analgesia in total knee arthroplasty
ChiCTR2500102304Phase 4Not yet recruiting
- Sponsor
- Xi'an Honghui Hospital
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of etoricoxib in knee osteoarthritis (OA) (2 arms), sponsored by Xi'an Honghui Hospital. Primary endpoints: Visual analog scale pain score, Knee joint function score and 3 more. Planned start May 2025; status: not yet recruiting.
02
Drugs
etoricoxib
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2500102304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500102304.